Newsletter | October 16, 2026

10.16.26 -- Traversing Complexity In Breast Cancer Clinical Development

SPONSOR

Webinar: Rethinking Starting Material: Whole Blood for Autologous T-Cell Manufacture

Could whole blood offer a practical alternative to leukapheresis for selected autologous T-cell therapy workflows? This webinar explores fit-for-purpose starting-material selection, cell requirements, recovery, processing logistics, and key variables such as hold time and anticoagulant choice. Learn how closed, automated cell-isolation approaches may help simplify processing, reduce patient burden, and support efficient, reproducible manufacturing across evolving cell therapy workflows. Click here to learn more.

FOCUS ON CLINICAL TRIALS

What LSPA's Life Sciences Future Says About The Road Ahead For CGT

By Erin Harris, Editor-In-Chief, Cell & Gene

The LSPA’s Life Sciences Future 2026 highlighted how shifting capital, M&A, global competition, and commercial pressures are reshaping CGT.

Traversing Complexity In Breast Cancer Clinical Development

White Paper | Worldwide Clinical Trials Oncology

Biomarkers, new therapies, and tough enrollment hurdles are reshaping breast cancer trials. Get the insights to plan smarter.

Measuring Investigational Drug Services With Time-Based Metrics

Article | By Rachael Aletti, McCreadie Group

Learn how adopting time-based metrics helps research teams accurately track workload, optimize staffing, and justify trial budgets.

Days Instead Of Weeks: What It Actually Takes To Close The DBL-To-TLF Gap

Webinar | Veristat, Inc.

The weeks after database lock often stall reporting. Here's how automated, deterministic TLF generation speeds up that timeline.

Unifying Research - Research Administration And Participant Caregiver

Audio | Univo IRB

Go behind the scenes of cancer clinical trials operations and hear a caregiver’s perspective on supporting a research participant, including the challenges, needs, and opportunities.

Why U.S. Sponsors Should Conduct Clinical Trials In Australia

Article | LabConnect

Faster approvals, refundable tax offsets, and a large patient population raise a pointed question: does Australia now outperform U.S. sites for early trial start-up?

CLINICAL TRIALS SOLUTIONS

•

Precision-ERA Medicine, Now In Autoimmune Mode - Precision for Medicine

SUPPLY CHAIN SOLUTIONS

•

Partial Filling, Seals And Sample Bags: Improved Bag Handling - Single Use Support

•

Bio-Pak® Small Volume Bio-Container Systems - Charter Medical

Connect With Cell & Gene: